Brinker Capital’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q2 | $8.87M | Buy |
14,216
+2,480
| +21% | +$1.55M | 0.28% | 75 |
|
|
2020
Q1 | $5.73M | Sell |
11,736
-2,829
| -19% | -$1.38M | 0.23% | 100 |
|
|
2019
Q4 | $5.47M | Buy |
14,565
+821
| +6% | +$308K | 0.17% | 128 |
|
|
2019
Q3 | $3.81M | Sell |
13,744
-406
| -3% | -$113K | 0.13% | 162 |
|
|
2019
Q2 | $4.43M | Sell |
14,150
-1,213
| -8% | -$380K | 0.16% | 133 |
|
|
2019
Q1 | $6.31M | Buy |
15,363
+1,893
| +14% | +$777K | 0.24% | 93 |
|
|
2018
Q4 | $5.03M | Sell |
13,470
-80
| -0.6% | -$29.9K | 0.22% | 103 |
|
|
2018
Q3 | $5.48M | Sell |
13,550
-705
| -5% | -$285K | 0.2% | 107 |
|
|
2018
Q2 | $4.92M | Buy |
14,255
+122
| +0.9% | +$42.1K | 0.19% | 112 |
|
|
2018
Q1 | $4.87M | Buy |
14,133
+4,269
| +43% | +$1.47M | 0.19% | 112 |
|
|
2017
Q4 | $3.71M | Buy |
9,864
+1,186
| +14% | +$446K | 0.14% | 152 |
|
|
2017
Q3 | $3.88M | Buy |
+8,678
| New | +$3.88M | 0.16% | 137 |
|
|
2017
Q2 | – | Sell |
-7,462
| Closed | -$2.89M | – | 842 |
|
|
2017
Q1 | $2.89M | Buy |
7,462
+2,505
| +51% | +$971K | 0.14% | 159 |
|
|
2016
Q4 | $1.82M | Buy |
+4,957
| New | +$1.82M | 0.1% | 198 |
|